Delivery Order SPE2DE24D0013-SPE2D626F678A

Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $12,240 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on December 2, 2025, with ultimate completion by December 9, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus—infectious disease detection capabilities that align with the agency's support of military medical readiness and defense healthcare operations. The contract contains no set-aside designation, reflecting Cepheid's established competitive position as a primary federal supplier of molecular diagnostic solutions. The work will be performed at Cepheid's headquarters in Sunnyvale, California.

This award represents a continuation of Cepheid's extensive federal contracting relationship with the Defense Logistics Agency Medical Supply Chain, which has issued numerous delivery orders for diagnostic testing supplies and reagents. Cepheid's federal supplier profile demonstrates substantial capability across multiple healthcare agencies, including the Department of Veterans Affairs, Indian Health Service, and Defense Health Agency, with notable prime contracts including a $32.8 million indefinite delivery contract with VA VISN 6 and a $6.7 million contract with VA VISN 17 for molecular diagnostic reagents and assays extending through 2029–2030. The firm fixed-price structure and modest ceiling value of this particular delivery order are consistent with Cepheid's typical federal procurement patterns for specialized diagnostic supplies supporting ongoing federal healthcare operations.